Catalyst Pharmaceuticals Inc logo

Catalyst Pharmaceuticals Inc

$ 12.70 -0.05 (-0.39%) 08:08 PM EST
P/E:
24.55
P/B:
5.33
Market Cap:
$ 1.31B
Enterprise V:
$ 1.09B
Volume:
1.82M
Avg Vol (2M):
4.04M
Also Trade In:
Volume:
1.82M
Market Cap $:
1.31B
PE Ratio:
24.55
Avg Vol (2-Month):
4.04M
Enterprise Value $:
1.09B
PB Ratio:
5.33
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
Name Current Vs Industry Vs History
Cash-To-Debt 54.5
Equity-to-Asset 0.9
Debt-to-Equity 0.02
Debt-to-EBITDA 0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 32.53
Distress
Grey
Safe
Beneish M-Score -2.85
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 48.59
9-Day RSI 43.39
14-Day RSI 45.95
6-1 Month Momentum % 74.11
12-1 Month Momentum % 181.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.79
Quick Ratio 10.44
Cash Ratio 9.82
Days Inventory 104.78
Days Sales Outstanding 16.99
Days Payable 44.31

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1

Financials (Next Earnings Date:2022-11-09 Est.)

CPRX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CPRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 170.465
EPS (TTM) ($) 0.51
Beta 0.66
Volatility % 68.02
14-Day RSI 45.95
14-Day ATR ($) 0.749055
20-Day SMA ($) 13.582
12-1 Month Momentum % 181.27
52-Week Range ($) 5.04 - 17.22
Shares Outstanding (Mil) 102.82

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Catalyst Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Catalyst Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.